Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-15, with 32 holding rows worth $179,342,000.

Accession
0001420506-18-001022
Filed
2018-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, 32 entries on the cover page, a total value of $179,342,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $179,342,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HANGER INC41043F208COMMON STOCK1,199,602$24,988,000thousands by filing date
TELIGENT INC NEW87960W104COM3,240,761$12,801,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW244,050$11,231,000thousands by filing date
MACROGENICS INC556099109COM457,475$9,808,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM96,428$9,351,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM1,661,940$9,307,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock63,930$8,405,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM715,317$8,047,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS1,337,191$7,555,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A80,155$6,553,000thousands by filing date
CIGNA CORPORATION125509109COM29,236$6,088,000thousands by filing date
ALLERGAN PLCG0177J108SHS31,400$5,981,000thousands by filing date
PROVIDENCE SVC CORP743815102COM85,217$5,733,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK162,905$5,369,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM274,410$4,780,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM2,720,089$4,624,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM119,578$4,441,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock253,631$4,439,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO23,400$4,242,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM341,457$4,097,000thousands by filing date
RETROPHIN INC761299956PUT102,300$2,939,000thousands by filing dateput
CENTENE CORP DEL COM15135B101Stock19,875$2,878,000thousands by filing date
AXOGEN INC05463X106COM76,741$2,828,000thousands by filing date
EVOLUS INC30052C107COM138,460$2,578,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM236,558$2,550,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD423,846$2,056,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock324,902$1,430,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW444,068$1,314,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM52,331$1,120,000thousands by filing date
OVASCIENCE INC69014Q101COM1,529,700$1,116,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK38,746$527,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM56,650$166,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-18-001022this filing2018-11-15acceptance time not in the bulk data set